Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rui Qu

Showing results (221-230 of 231) with videos related to

Pageof 24
Sort By:
Biorxiv : the Preprint Server for Biology|May 20, 2024
Epigenetic targeting of PGBD5-dependent DNA damage in SMARCB1-deficient sarcomasYaniv Kazansky, Helen S Mueller, Daniel Cameron, et al.
The Journal of Clinical Investigation|August 12, 2025
Epigenetic targeting of PGBD5-dependent DNA damage in SMARCB1-deficient sarcomasYaniv Kazansky, Helen S Mueller, Daniel Cameron, et al.
Science Advances|September 27, 2024
ATR inhibition activates cancer cell cGAS/STING-interferon signaling and promotes antitumor immunity in small-cell lung cancerHirokazu Taniguchi, Subhamoy Chakraborty, Nobuyuki Takahashi, et al.
Biorxiv : the Preprint Server for Biology|August 23, 2023
Interferon response and epigenetic modulation by <i>SMARCA4</i> mutations drive ovarian tumor immunogenicityMelica Nourmoussavi Brodeur, Higinio Dopeso, Yingjie Zhu, et al.
Cell Reports|May 18, 2022
WEE1 inhibition enhances the antitumor immune response to PD-L1 blockade by the concomitant activation of STING and STAT1 pathways in SCLCHirokazu Taniguchi, Rebecca Caeser, Shweta S Chavan, et al.
ACS Nano|March 30, 2022
An Ultrasound-Induced Self-Clearance Hydrogel for Male Reversible ContraceptionZi-Qi Wang, Zhong-Qing Liu, Chang-Hao Zhao, et al.
Nature|May 31, 2023
Pan-KRAS inhibitor disables oncogenic signalling and tumour growthDongsung Kim, Lorenz Herdeis, Dorothea Rudolph, et al.
Stroke|July 27, 2023
Global, Regional, and National Economic Consequences of StrokeJakob V E Gerstl, Sarah E Blitz, Qing Rui Qu, et al.
Nature Nanotechnology|August 15, 2025
Designing lipid nanoparticles using a transformer-based neural networkAlvin Chan, Ameya R Kirtane, Qing Rui Qu, et al.
Science Advances|December 4, 2024
Interferon response and epigenetic modulation by <i>SMARCA4</i> mutations drive ovarian tumor immunogenicityMelica Nourmoussavi Brodeur, Higinio Dopeso, Yingjie Zhu, et al.
Pageof 24

Showing results (221-230 of 231) with videos related to

Sort By:
Pageof 24
Biorxiv : the Preprint Server for Biology|May 20, 2024
Epigenetic targeting of PGBD5-dependent DNA damage in SMARCB1-deficient sarcomasYaniv Kazansky, Helen S Mueller, Daniel Cameron, et al.
The Journal of Clinical Investigation|August 12, 2025
Epigenetic targeting of PGBD5-dependent DNA damage in SMARCB1-deficient sarcomasYaniv Kazansky, Helen S Mueller, Daniel Cameron, et al.
Science Advances|September 27, 2024
ATR inhibition activates cancer cell cGAS/STING-interferon signaling and promotes antitumor immunity in small-cell lung cancerHirokazu Taniguchi, Subhamoy Chakraborty, Nobuyuki Takahashi, et al.
Biorxiv : the Preprint Server for Biology|August 23, 2023
Interferon response and epigenetic modulation by <i>SMARCA4</i> mutations drive ovarian tumor immunogenicityMelica Nourmoussavi Brodeur, Higinio Dopeso, Yingjie Zhu, et al.
Cell Reports|May 18, 2022
WEE1 inhibition enhances the antitumor immune response to PD-L1 blockade by the concomitant activation of STING and STAT1 pathways in SCLCHirokazu Taniguchi, Rebecca Caeser, Shweta S Chavan, et al.
ACS Nano|March 30, 2022
An Ultrasound-Induced Self-Clearance Hydrogel for Male Reversible ContraceptionZi-Qi Wang, Zhong-Qing Liu, Chang-Hao Zhao, et al.
Nature|May 31, 2023
Pan-KRAS inhibitor disables oncogenic signalling and tumour growthDongsung Kim, Lorenz Herdeis, Dorothea Rudolph, et al.
Stroke|July 27, 2023
Global, Regional, and National Economic Consequences of StrokeJakob V E Gerstl, Sarah E Blitz, Qing Rui Qu, et al.
Nature Nanotechnology|August 15, 2025
Designing lipid nanoparticles using a transformer-based neural networkAlvin Chan, Ameya R Kirtane, Qing Rui Qu, et al.
Science Advances|December 4, 2024
Interferon response and epigenetic modulation by <i>SMARCA4</i> mutations drive ovarian tumor immunogenicityMelica Nourmoussavi Brodeur, Higinio Dopeso, Yingjie Zhu, et al.
Pageof 24